Advertisement

PharmacoEconomics

, Volume 6, Issue 3, pp 240–248 | Cite as

Identifying Costs of Intravenous Solution Wastage

  • Kathryn M. Uchida
  • Scott A. Iteen
  • Noreen T. Wong
Original Research Article Identifying Costs of IV Wastage

Abstract

A monitoring programme to systematically evaluate and decrease wastage of intravenous (IV) solutions was developed. Documentation of type and quantity of wasted solutions can help identify potential causes of waste. Subsequent systems changes intended to decrease waste can then be evaluated. Pharmacy technicians daily recorded the number, identity and locations of discarded IV solutions. A computer spreadsheet application was developed and used to produce a monthly summary identifying the number, drug cost and solutions wasted by hospital unit, thus establishing specific areas to target for IV wastage control. Investigators conducted a 12-month retrospective eva luation of IV wastage, revealing that over 14000 IV preparations were destroyed at an estimated $US90 000 in drug costs. This equates to 2.5% of total drug costs wasted in small volume parenterals. Target programmes were implemented for drugs that were frequently wasted and systems changes implemented that decreased overall wastage of IV solutions.

Keywords

Dobutamine Ondansetron Total Parenteral Nutrition Drug Cost Idarubicin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Salberg DJ. Newton RW. Leduc DT. Cost of wastage in a hospital intravenous admixture program. Hosp Formul 1984: 19: 375–8PubMedGoogle Scholar
  2. 2.
    Newhouse JG, Paul VM. Waugh NA. el al. Reducing IV waste to under 2.25 percent. Hosp Pharm 1988; 23: 241–7PubMedGoogle Scholar
  3. 3.
    Diehl LD, Goo ED. Sumiye L. et al. Reducing waste of intravenous solutions. Am J Hosp Pharm 1992; 49: 106–8PubMedGoogle Scholar
  4. 4.
    Mitchell SR. Monitoring waSte in an intravenous admixture program. Am J Hosp Pharm 1987; 44: 106–11PubMedGoogle Scholar
  5. 5.
    Billiter M. Nowak MM. Rapp RP. et al. Waste of IV admixtures in the ADD-Vantage system and a traditional minibag system.Am J Hosp Pharm 1990; 47: 1598–600Google Scholar
  6. 6.
    Larson N. McCarthy MT. Fruin DM. et al. Reducing IV room Waste through pharmacy and nursing collaborative practice.27th Annual AsHP Midyear Clinical Meeting. Dec 1992. Orlando,Florida: 1992Google Scholar
  7. 7.
    Birdwell SW. Meyer CE. Scheckelhoff OJ. et al. Survey of wastage from intravenous admixture systems in US hospitals. Pharmaco Economics 1993: 4: 271–7CrossRefGoogle Scholar
  8. 8.
    ASHP technical assistance bulletin on assessing coSt-containment strategies for institutional pharmacies. Am J Hosp Pharm 1985: 42: 1583–91Google Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Kathryn M. Uchida
    • 1
  • Scott A. Iteen
    • 1
  • Noreen T. Wong
    • 1
  1. 1.UCI Medical CenterOrangeUSA

Personalised recommendations